Tax benefit brings Gujarat back in favour with drug cos

February 5, 2009
1 min read

Gujarat, the traditional centre of gravity of the pharma business in India that had lost out to states such as Himachal Pradesh, Goa, and Uttarakhand in the past few years, is regaining lost ground on the strength of tax cuts announced in last year’s budget.

Pharma firms, including around 100 small- and medium-sized ones, are planning manufacturing facilities in two pharma parks in the state at a total investment of Rs1,000 crore.

At the new Gujarat Techno Pharma Park in Changodar near Ahmedabad, at least 35 units are nearing completion. And 71 firms have agreed to set up shop in a Gujarat Industrial Development Corporation (GIDC) park, said R.S. Joshi, executive secretary, state chapter of industry lobby the Indian Drug Manufacturers Association (IDMA).

In addition, Ahmedabad-based biotech firm Intas Biopharmaceuticals Ltd has agreed to set up a Rs100 crore manufacturing facility in Sanand.

The new GIDC park is jointly promoted by the government of Gujarat and the state chapter of Idma, while the Gujarat Techno Park is a private venture.

Apart from the small and medium enterprises, other companies putting up factories are Cadila Healthcare Ltd, Triokka Pharma Ltd, Lincoln Pharmaceuticals Ltd, Osho Pharmaceuticals Ltd, Sunish Pharmaceuticals Ltd, Medico Pharmaceuticals Ltd, Peri Pharma Ltd and Medwin Pharma Ltd.

Gujarat, which once accounted for at least half of all pharmaceutical exports, saw this proportion decline between 2000 and 2004 when drug firms shifted to Himachal Pradesh, Uttaranchal, Jammu and Kashmir and Goa to avail of incentives.

In last year’s Union budget, however, the government changed laws governing excise duty (a tax levied on manufactured goods) and this has made many companies look to Gujarat, which with its established cluster of pharma firms, access to ports and availability of power, remains a prime location for manufacturing, according to analysts.

“Under the new excise duty structure, the units at the so-called duty-free regions are paying 4% more duty compared with the units outside as they cannot use the 4% Modvat claim on raw material,

Previous Story

Special Economic Zones & Service Tax – Issues & Implications

Next Story

The Value of ‘Other People’s Money’

Latest from Blog

Income Tax deduction for procurements from MSMEs only upon actual payment

By Shaleen Shah | LinkedIn, assisted by Divyansh Jain Introduction This Note is relevant to computation of income under the head ‘Income from business and profession’. Section 43B of the Income Tax Act provides a list of expenses allowed as deduction, on cash basis irrespective of the year of accounting.

Foreign companies may be required to file Tax Returns in India

by Nexdigm Private Limited as published on Impact of increase in withholding tax on rates for Fees for Technical Services and Royalty As per Indian Tax laws1, payments made to Non-Residents/Foreign Companies for Fees for Technical Services (FTS) and Royalties were liable to tax at the effective tax rate of

How Cryptocurrencies Are Taxed In India

[Source:; Authors: Justin M Bharucha, Aashika Jain] Cryptocurrencies and non-fungible tokens (NFTs) are presently unregulated in India. While the Reserve Bank of India (RBI) had sought to ban cryptocurrencies in 2018, the Supreme Court quashed the attempted ban leaving cryptocurrencies in regulatory limbo – neither illegal nor, strictly speaking,

Higher rate of TDS in certain situations from 1st July 2021

[By Shaleen Shah (Partner), VNCA] Finance Act 2021, has introduced a new section 206AB effective from 1-Jul-2021 wherein a payer/buyer is responsible to deduct TDS at higher rate (i.e. twice the rate as specified under the relevant provision of the Income Tax Act or twice the rate/ rates in force;

Don't Miss

How Cryptocurrencies Are Taxed In India

[Source:; Authors: Justin M Bharucha, Aashika Jain] Cryptocurrencies and

Only 329 startups can claim tax holiday under Startup India

[Source:] Exactly five years since the launch of the